Company intelligence / Profile preview

Cryosa

Arden Hills, Minnesota, United Statescryosa.com ↗

Ownership: Private
Employees: ~29
Development stage: Other

Overview

Cryosa is developing a minimally invasive, permanent medical device therapy for moderate to severe obstructive sleep apnea. The company has completed extensive preclinical safety and efficacy testing and has raised funding to support first-in-human clinical trials. As of the latest available information, no active clinical trials are listed on ClinicalTrials.gov[3][4].

Therapeutic areas: Pulmonology
Modalities: DeviceNon-pharmacological therapy
Industry: Implantable Medical Devices

Beyond the preview

Go deeper on Cryosa.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cryosa.

Explore the full profile